George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - ERGOMED PLC

6 Oct 2023 14:40

RNS Number : 0260P
Barclays PLC
06 October 2023
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

ERGOMED PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

05 Oct 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

860,114

1.69%

22,746

0.04%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

21,539

0.04%

849,732

1.67%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

881,653

1.73%

872,478

1.71%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

8,838

13.3996 GBP

1p ordinary

Purchase

3,241

13.4000 GBP

1p ordinary

Purchase

1,960

13.3793 GBP

1p ordinary

Purchase

1,045

13.3800 GBP

1p ordinary

Purchase

18

13.4377 GBP

1p ordinary

Sale

566,993

13.4000 GBP

1p ordinary

Sale

4,623

13.3915 GBP

1p ordinary

Sale

1,052

13.3800 GBP

1p ordinary

Sale

542

13.4011 GBP

1p ordinary

Sale

274

13.4007 GBP

1p ordinary

Sale

223

13.3804 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

SWAP

Short

4,193

13.4000 GBP

1p ordinary

SWAP

Short

4,645

13.3993 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

06 Oct 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFLFVVIDLRIIV
Date   Source Headline
14th Nov 20237:00 amRNSCancellation - Ergomed plc
13th Nov 20233:30 pmRNSForm 8.3 - ERGO LN
13th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
13th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
13th Nov 202310:37 amRNSScheme of Arrangement becomes Effective
13th Nov 202310:24 amRNSForm 8.5 (EPT/RI) - Ergomed Plc
13th Nov 20237:30 amRNSSuspension - Ergomed plc
10th Nov 20233:47 pmRNSHolding(s) in Company
10th Nov 20233:30 pmRNSForm 8.3 - ERGO LN
10th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
10th Nov 20233:29 pmRNSForm 8.3 - Ergomed plc
10th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
10th Nov 20233:15 pmPRNForm 8.3 - Ergomed Plc
10th Nov 20233:05 pmRNSHolding(s) in Company
10th Nov 202312:05 pmGNWForm 8.3 - Ergomed PLC
10th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
10th Nov 202310:50 amGNWMan Group PLC : Form 8.3 - Ergomed plc
10th Nov 202310:45 amRNSForm 8.3 - Ergomed plc
9th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
9th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
9th Nov 20232:27 pmRNSIssue of Equity and Rule 2.9 Announcement
9th Nov 20232:16 pmRNSCourt Sanction of the Scheme of Arrangement
9th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
8th Nov 20236:00 pmRNSErgomed
8th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
8th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
8th Nov 20238:12 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
7th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
6th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
6th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
6th Nov 20232:04 pmGNWForm 8.3 - Ergomed Plc
6th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
6th Nov 202311:50 amRNSForm 8.3 - Ergomed plc
6th Nov 20238:34 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
3rd Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
3rd Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
3rd Nov 20239:33 amGNWMan Group PLC : Form 8.3 - Ergomed plc
2nd Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
2nd Nov 20233:21 pmRNSStatement re Publication of Finance Documentation
2nd Nov 202312:48 pmGNWForm 8.3 - Ergomed Plc
2nd Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
2nd Nov 202311:45 amRNSForm 8.3 - Ergomed plc
2nd Nov 20237:59 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
1st Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
1st Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
1st Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
1st Nov 202311:25 amRNSForm 8.3 - Ergomed plc
1st Nov 20238:50 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
1st Nov 20237:00 amRNSIssue of Equity and Rule 2.9 Announcement
31st Oct 20235:09 pmGNWForm 8.3 - Ergomed plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.